KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on May 25, 2026 - 3:59PM >>  ABB India 6765.65  [ 1.15% ]  ACC 1382.5  [ 1.71% ]  Ambuja Cements 441.85  [ 1.26% ]  Asian Paints 2655.9  [ 0.64% ]  Axis Bank 1310  [ 1.93% ]  Bajaj Auto 10491.3  [ -0.53% ]  Bank of Baroda 271.65  [ 2.51% ]  Bharti Airtel 1875.05  [ 0.20% ]  Bharat Heavy 419.35  [ 2.64% ]  Bharat Petroleum 308.25  [ 4.30% ]  Britannia Industries 5323.5  [ -0.25% ]  Cipla 1413  [ 1.00% ]  Coal India 458  [ 0.34% ]  Colgate Palm 2095.8  [ -2.86% ]  Dabur India 447.15  [ -0.91% ]  DLF 592.35  [ 0.96% ]  Dr. Reddy's Lab. 1334.1  [ 2.07% ]  GAIL (India) 168.7  [ 4.72% ]  Grasim Industries 3169.65  [ 0.44% ]  HCL Technologies 1166.55  [ 0.24% ]  HDFC Bank 786.85  [ 2.67% ]  Hero MotoCorp 4980.85  [ 0.31% ]  Hindustan Unilever 2197.45  [ -0.21% ]  Hindalco Industries 1099.25  [ -0.93% ]  ICICI Bank 1291.6  [ 2.11% ]  Indian Hotels Co. 663.7  [ 2.04% ]  IndusInd Bank 927.15  [ 1.81% ]  Infosys 1168.65  [ -0.49% ]  ITC 304  [ 0.75% ]  Jindal Steel 1215.4  [ 0.46% ]  Kotak Mahindra Bank 392.75  [ 2.23% ]  L&T 4033.3  [ 2.71% ]  Lupin 2291  [ 0.50% ]  Mahi. & Mahi 3143.9  [ 2.00% ]  Maruti Suzuki India 13170.7  [ 1.41% ]  MTNL 29.77  [ 1.60% ]  Nestle India 1419.5  [ -0.26% ]  NIIT 68.95  [ 4.60% ]  NMDC 90.17  [ 2.61% ]  NTPC 390.05  [ 0.41% ]  ONGC 284.95  [ -1.74% ]  Punj. NationlBak 106.2  [ 3.51% ]  Power Grid Corpn. 295.25  [ 0.31% ]  Reliance Industries 1366.85  [ 0.90% ]  SBI 969.9  [ 2.19% ]  Vedanta 332.65  [ 0.79% ]  Shipping Corpn. 302.8  [ -4.30% ]  Sun Pharmaceutical 1841.3  [ -0.21% ]  Tata Chemicals 765.9  [ 2.15% ]  Tata Consumer 1187.25  [ -0.47% ]  Tata Motors Passenge 373  [ 2.64% ]  Tata Steel 210.2  [ 0.48% ]  Tata Power Co. 413.5  [ 1.15% ]  Tata Consult. Serv. 2307.75  [ -0.41% ]  Tech Mahindra 1437.25  [ 1.09% ]  UltraTech Cement 11722.85  [ 1.28% ]  United Spirits 1285  [ 0.12% ]  Wipro 206.8  [ 1.82% ]  Zee Entertainment 82.69  [ 0.62% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

MEDICAMEN BIOTECH LTD.

25 May 2026 | 03:49

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE646B01010 BSE Code / NSE Code 531146 / MEDICAMEQ Book Value (Rs.) 204.24 Face Value 10.00
Bookclosure 19/09/2025 52Week High 449 EPS 5.24 P/E 51.65
Market Cap. 367.13 Cr. 52Week Low 217 P/BV / Div Yield (%) 1.33 / 0.37 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
MBL was incorporated as a public limited company under the Companies Act, 1956, on December 22, 1993. The certificate of commencement of business was obtained on January 31, 1994. The company has jointly been promoted by Mr.V.Kumar, Mr.Bal Kishan Gupta, Mr.Lakhvinder Singh Arora and Mr.Ranjit Singh. MBL is engaged in marketing of various drugs in the domestic and export markets. Company is procuring drugs from various reputed manufactures viz. Hoechst, Cadila, Hindustan Ciba, Purepharma, Oboi Labs etc. and exporting to countries like Germany, Russia, Holland, CIS (Confederation of Independent States) etc. part from domestic ethical and institutional sales. MBL has obtained permission for production of tablets, capsules and liquid orals under loan licence basis from Delhi Drug Control Authority and Madhya Pardesh Drug Control Authority on Welbeck Pharmaceutical Private Limited, New Delhi and Pure Pharma Private Limited, Indore respectively. 2010 -The Company has recommended a final dividend of Rs. 0.75 per equity share (being 7.5% on the face value of Rs. 10 per share) -The Company appointed Mr. B.K.Gupta as Managing Director. 2011 -The Company gets ANVISA.Brazil approval for Non Beta Lactum solid Tablets and Coated tablets manufactured at its Plant situated at SP 1192,A & B, Phase 4, Bhiwadi - 301019, Rajasthan. 2013 -Ms. Harshita Sharma has been appointed as Additional Director of the company. 2016 -Shivalik Rasayan Ltd take controlling stake of Medicamen Biotech Ltd. 2019 -FABD(Philippines), CECMED(Cuba)-Bhiwadi FDF Plant. 2020 -Global API Facility started Dahej API Plant. 2021 -Operations started Haridwar formulation Unit II(FDF). 2023 -Medicamen Biotech Gains On Successful Anda Filing For Bortezomib Injections.

2024
-Medicamen Biotech's Bhiwadi Manufacturing Facility Secures EU GMP Approval from Greece.
-Medicamen Biotech's Sterile injectable Facility Received USFDA Approval.